Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genome-Based Epidemiological Analysis of 13 Acinetobacter Strains Isolated from Blood Cultures of Hospitalized Patients from a University Hospital in Japan.
Oinuma KI, Suzuki M, Nakaie K, Sato K, Saeki K, Sakiyama A, Takizawa E, Niki M, Niki M, Yamada K, Shibayama K, Kakeya H, Kaneko Y. Oinuma KI, et al. Among authors: sakiyama a. Jpn J Infect Dis. 2019 Jul 24;72(4):274-280. doi: 10.7883/yoken.JJID.2018.403. Epub 2019 Feb 28. Jpn J Infect Dis. 2019. PMID: 30814458 Free article.
Discovery of anti-mucoviscous activity of rifampicin and its potential as a candidate antivirulence agent against hypervirulent Klebsiella pneumoniae.
Namikawa H, Oinuma KI, Sakiyama A, Tsubouchi T, Tahara YO, Yamada K, Niki M, Takemoto Y, Miyata M, Kaneko Y, Shuto T, Kakeya H. Namikawa H, et al. Among authors: sakiyama a. Int J Antimicrob Agents. 2019 Aug;54(2):167-175. doi: 10.1016/j.ijantimicag.2019.05.018. Epub 2019 Jun 5. Int J Antimicrob Agents. 2019. PMID: 31173862
Clinical characteristics of bacteremia caused by hypermucoviscous Klebsiella pneumoniae at a tertiary hospital.
Namikawa H, Yamada K, Sakiyama A, Imoto W, Yamairi K, Shibata W, Yoshii N, Niki M, Nakaie K, Oinuma KI, Tsubouchi T, Niki M, Tochino Y, Takemoto Y, Kaneko Y, Shuto T, Kakeya H. Namikawa H, et al. Among authors: sakiyama a. Diagn Microbiol Infect Dis. 2019 Sep;95(1):84-88. doi: 10.1016/j.diagmicrobio.2019.04.008. Epub 2019 Apr 26. Diagn Microbiol Infect Dis. 2019. PMID: 31256940
Clinical and virulence factors related to the 30-day mortality of Klebsiella pneumoniae bacteremia at a tertiary hospital: a case-control study.
Namikawa H, Niki M, Niki M, Yamada K, Nakaie K, Sakiyama A, Oinuma KI, Tsubouchi T, Tochino Y, Takemoto Y, Kaneko Y, Shuto T, Kakeya H. Namikawa H, et al. Among authors: sakiyama a. Eur J Clin Microbiol Infect Dis. 2019 Dec;38(12):2291-2297. doi: 10.1007/s10096-019-03676-y. Epub 2019 Oct 11. Eur J Clin Microbiol Infect Dis. 2019. PMID: 31605255
Genomic characterization of triple-carbapenemase-producing Acinetobacter baumannii.
Oinuma KI, Suzuki M, Sakiyama A, Tsubouchi T, Saeki K, Sato K, Niki M, Yamada K, Shibayama K, Kakeya H, Kaneko Y. Oinuma KI, et al. Among authors: sakiyama a. JAC Antimicrob Resist. 2021 Dec 18;3(4):dlab191. doi: 10.1093/jacamr/dlab191. eCollection 2021 Dec. JAC Antimicrob Resist. 2021. PMID: 34934945 Free PMC article.
Rifampicin exerts anti-mucoviscous activity against hypervirulent Klebsiella pneumoniae via binding to the RNA polymerase β subunit.
Tohda M, Oinuma KI, Sakiyama A, Tsubouchi T, Niki M, Namikawa H, Yamane K, Yamada K, Watanabe T, Asai K, Kakeya H, Kaneko Y, Kawaguchi T. Tohda M, et al. Among authors: sakiyama a. J Glob Antimicrob Resist. 2023 Mar;32:21-28. doi: 10.1016/j.jgar.2022.11.018. Epub 2022 Dec 23. J Glob Antimicrob Resist. 2023. PMID: 36572148 Free article.
37 results